Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
The Captial Market (CapitalMarket.com) rating for Blue Jet Healthcare IPO is 37. Their analysis recommends Do Not Subscribe for the IPO.
| Reviewer | Rating Score | Rating |
|---|---|---|
| Capital Market | 37 | Do Not Subscribe |
[Dilip Davda] BJHL has created a niche place in the global markets for the products manufactured by it and enjoys long term relationship with marquee customers and FMCGs. It is on capacity expansion spree and hopes to improve its performance in coming years. On the basis of annualized FY24 earnings, the issue appears fully priced. Investors may park funds for the medium to long-term rewards in this long race horse. Read detail review...
Blue Jet Healthcare Limited peer comparison with similar listed entities. () (As on October 24, 2023)
| Company Name | EPS (Rs) | P/E (x) | RoNW (%) | |
|---|---|---|---|---|
| EPS Basic | EPS Diluted | |||
| Blue Jet Healthcare Limited | 9.23 | 9.23 | 37.49 | 23.48 |
There are no listed companies in India that engage in a business similar to that of Blue Jet Healthcare Limited. Accordingly, it is not possible to provide an industry comparison in relation to the Company.
Blue Jet Healthcare IPO Reviews, analysis and views by popular members. Read Blue Jet Healthcare Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
Useful Articles
RHP